-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ninerafaxstat in Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ninerafaxstat in Coronary Artery Disease (CAD) (Ischemic Heart Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ninerafaxstat in Coronary Artery Disease (CAD) (Ischemic...
-
Product Insights
Autism Spectrum Disorder (ASD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Autism Spectrum Disorder (ASD) - Drugs In Development, 2023’, provides an overview of the Autism Spectrum Disorder (ASD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Autism Spectrum Disorder (ASD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Panic Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Panic Disorders - Drugs In Development, 2023’, provides an overview of the Panic Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Panic Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cannabidiol 2 in Autism Spectrum Disorder (ASD)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Cannabidiol 2 in Autism Spectrum Disorder (ASD) Drug Details:Cannabidiol is under development for the treatment of pervasive...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RMC-6236 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RMC-6236 in Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.RMC-6236 in Colorectal Cancer Drug Details:RMC-6236 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cannabidiol Isolate in Menstrual Disorders
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Cannabidiol Isolate in Menstrual Disorders Drug Details:Cannabidiol isolate is under development for the treatment of menstrual-related symptoms....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AB-1005 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AB-1005 in Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AB-1005 in Multiple...
-
Company Insights
Innovation and Patenting activity of Canopy Growth Corp Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Canopy Growth Corp Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Profile
Canopy Growth Corp – Company Profile
Canopy Growth Corp (Canopy Growth), a subsidiary of Constellation Brands Inc, is a cannabis company that carries the production, distribution and marketing of a range of cannabis and hemp-based products for medical and recreational businesses. The company offers cannabis products including curated cannabis varieties including soft gel capsules, dried cannabis flowers, vapes, and edibles. beverages, oils and concentrates and cannabis accessories. Canopy Growth also provides hemp-derived CBD products such as topical creams, oils and soft gels and nutrition beverages. The...
Add to Basket -
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...